Fumitremorgin C Attenuates Osteoclast Formation and Function via Suppressing RANKL-Induced Signaling Pathways

Fumitremorgin C Attenuates Osteoclast Formation and Function via Suppressing RANKL-Induced Signaling Pathways

Excessive bone resorption conducted by osteoclasts is considered as the main cause of osteoclast-related bone diseases such as osteoporosis. Therefore, the suppression of excessive osteoclast formation and function is one of the strategies to treat osteoclast-related bone diseases. Fumitremorgin C (...

Full description

Bibliographic Details
Main Authors:	Yu Yuan, Kai Chen, Xi Chen, Chao Wang, Heng Qiu, Zhen Cao, Dezhi Song, Youqiang Sun, Jianmin Guo, Jennifer Tickner, Jiake Xu, Jun Zou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-03-01
Series:	Frontiers in Pharmacology
Subjects:	fumitremorgin C osteoclast osteoporosis NFATc1 MAPK
Online Access:	https://www.frontiersin.org/article/10.3389/fphar.2020.00238/full

Similar Items

Vindoline Inhibits RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss in Mice
by: Yunfei Zhan, et al.
Published: (2020-01-01)

Sitagliptin, An Anti-diabetic Drug, Suppresses Estrogen Deficiency-Induced OsteoporosisIn Vivo and Inhibits RANKL-Induced Osteoclast Formation and Bone Resorption In Vitro
by: Chuandong Wang, et al.
Published: (2017-06-01)

Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS Activity
by: Jianbo He, et al.
Published: (2021-09-01)

6′-O-Galloylpaeoniflorin Attenuates Osteoclasto-genesis and Relieves Ovariectomy-Induced Osteoporosis by Inhibiting Reactive Oxygen Species and MAPKs/c-Fos/NFATc1 Signaling Pathway
by: Wenjie Liu, et al.
Published: (2021-04-01)

Peiminine Suppresses RANKL-Induced Osteoclastogenesis by Inhibiting the NFATc1, ERK, and NF-κB Signaling Pathways
by: Mengbo Zhu, et al.
Published: (2021-09-01)

Water Extracts of Hull-less Waxy Barley (<i>Hordeum vulgare</i> L.) Cultivar ‘Boseokchal’ Inhibit RANKL-induced Osteoclastogenesis
by: Kwang-Jin Kim, et al.
Published: (2019-10-01)

Notopterol Attenuates Estrogen Deficiency-Induced Osteoporosis via Repressing RANKL Signaling and Reactive Oxygen Species
by: Delong Chen, et al.
Published: (2021-06-01)

Daily chemical evodiamine from Chinese prickly ash attenuates osteoclast differentiation through RANKL induced NFAT pathways
by: Lei Jiang, et al.
Published: (2017-10-01)

Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis
by: Minsun Kim, et al.
Published: (2020-02-01)

Sarsasapogenin Suppresses RANKL-Induced Osteoclastogenesis in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo
by: Peng J, et al.
Published: (2020-08-01)

<i>Eleutherococcus sessiliflorus</i> Inhibits Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Induced Bone Loss
by: Sang-Yong Han, et al.
Published: (2021-03-01)

Hesperetin Prevents Bone Resorption by Inhibiting RANKL-Induced Osteoclastogenesis and Jnk Mediated Irf-3/c-Jun Activation
by: Qiang Zhang, et al.
Published: (2018-09-01)

Total flavonoids from celery suppresses RANKL-induced osteoclast differentiation and bone resorption function via attenuating NF-κB and p38 pathways in RAW264.7 cells
by: Lujuan Jia, et al.
Published: (2020-06-01)

Transcriptome Analysis Reveals That <i>Abeliophyllum distichum</i> Nakai Extract Inhibits RANKL-Mediated Osteoclastogenensis Mainly Through Suppressing Nfatc1 Expression
by: Kyubin Lee, et al.
Published: (2020-08-01)

Amyloid β Peptide Enhances RANKL-Induced Osteoclast Activation through NF-κB, ERK, and Calcium Oscillation Signaling
by: Shangfu Li, et al.
Published: (2016-10-01)

Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB
by: Gui-Hua Quan, et al.
Published: (2015-12-01)

Betulin Suppresses Osteoclast Formation via Down-Regulating NFATc1
by: Kwang-Jin Kim, et al.
Published: (2018-06-01)

Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways
by: Xiao Chen, et al.
Published: (2018-12-01)

Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways
by: Xue Yang, et al.
Published: (2021-06-01)

The Inhibition of RANKL-Induced Osteoclastogenesis through the Suppression of p38 Signaling Pathway by Naringenin and Attenuation of Titanium-Particle-Induced Osteolysis
by: Wengang Wang, et al.
Published: (2014-11-01)

Necrostatin－7 suppresses RANK－NFATc1 signaling and attenuates macrophage to osteoclast differentiation
by: Fuji, Hiroaki
Published: (2019)

PSTP-3,5-Me Inhibits Osteoclast Differentiation and Bone Resorption
by: Eunjin Cho, et al.
Published: (2019-09-01)

Hexosamine Biosynthetic Pathway-Derived O-GlcNAcylation Is Critical for RANKL-Mediated Osteoclast Differentiation
by: Myoung Jun Kim, et al.
Published: (2021-08-01)

Ethyl Acetate Fraction of Aqueous Extract of <i>Lentinula edodes</i> Inhibits Osteoclastogenesis by Suppressing NFATc1 Expression
by: Hyerim Lee, et al.
Published: (2020-02-01)

Effect of Usnic Acid on Osteoclastogenic Activity
by: Kwang-Jin Kim, et al.
Published: (2018-10-01)

Kynurenine Promotes RANKL–Induced Osteoclastogenesis In Vitro by Activating the Aryl Hydrocarbon Receptor Pathway
by: Nada H. Eisa, et al.
Published: (2020-10-01)

Involvement of PU.1 in NFATc1 promoter function in osteoclast development
by: Kentaro Ishiyama, et al.
Published: (2015-07-01)

Betulinic Acid Protects From Bone Loss in Ovariectomized Mice and Suppresses RANKL-Associated Osteoclastogenesis by Inhibiting the MAPK and NFATc1 Pathways
by: Jiyong Wei, et al.
Published: (2020-07-01)

Suppression Effect of Astaxanthin on Osteoclast Formation In Vitro and Bone Loss In Vivo
by: Yun-Ho Hwang, et al.
Published: (2018-03-01)

Anemonin Attenuates RANKL-Induced Osteoclastogenesis and Ameliorates LPS-Induced Inflammatory Bone Loss in Mice via Modulation of NFATc1
by: Huanhuan Hou, et al.
Published: (2020-02-01)

β-Boswellic Acid Inhibits RANKL-Induced Osteoclast Differentiation and Function by Attenuating NF-κB and Btk-PLCγ2 Signaling Pathways
by: Gyeong Do Park, et al.
Published: (2021-05-01)

Pristimerin Protects Against OVX-Mediated Bone Loss by Attenuating Osteoclast Formation and Activity via Inhibition of RANKL-Mediated Activation of NF-κB and ERK Signaling Pathways
by: Li X, et al.
Published: (2021-01-01)

Phillyrin Attenuates Osteoclast Formation and Function and Prevents LPS-Induced Osteolysis in Mice
by: Jing Wang, et al.
Published: (2019-10-01)

Drug delivery to osteoclast receptor targets
by: Kalvapalle, Rohit
Published: (2009)

The Role of BMP Signaling in Osteoclast Regulation
by: Brian Heubel, et al.
Published: (2021-06-01)

Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways
by: Lin Zhou, et al.
Published: (2015-11-01)

Reactive Oxygen Species in Osteoclast Differentiation and Possible Pharmaceutical Targets of ROS-Mediated Osteoclast Diseases
by: Taiwo Samuel Agidigbi, et al.
Published: (2019-07-01)

Water extract of Cnidii Rhizoma suppresses RANKL-induced osteoclastogenesis in RAW 264.7 cell by inhibiting NFATc1/c-Fos signaling and prevents ovariectomized bone loss in SD-rat
by: Ka-Yeon Lee, et al.
Published: (2019-08-01)

Bisphosphonates Reduce Smoking-Induced Osteoporotic-Like Alterations by Regulating RANKL/OPG in an Osteoblast and Osteoclast Co-Culture Model
by: Sheng Zhu, et al.
Published: (2021-12-01)

Molecular and cellular characterizations of human cherubism: disease aggressiveness depends on osteoclast differentiation
by: Natacha Kadlub, et al.
Published: (2018-09-01)

Cannot write session to /tmp/vufind_sessions/sess_l9bt0b37i9ufjhhl2ltdin8phv